ImmunityBio (IBRX) Interest Coverage Ratio (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.75% |
| Dec 31, 2025 | -19.51% |
| Sep 30, 2025 | 20.85% |
| Jun 30, 2025 | -9.49% |
| Mar 31, 2025 | -57.76% |
| Dec 31, 2024 | 2.55% |
| Sep 30, 2024 | 17.93% |
| Jun 30, 2024 | -3.19% |
| Mar 31, 2024 | 98.49% |
| Dec 31, 2023 | -9,229.17% |
| Sep 30, 2023 | 13.37% |
| Jun 30, 2023 | 29.42% |
| Mar 31, 2023 | -182.22% |
| Dec 31, 2022 | 184.03% |
| Sep 30, 2022 | 34.03% |
| Jun 30, 2022 | 27.36% |
| Mar 31, 2022 | 35.98% |
| Dec 31, 2021 | 19.06% |
| Sep 30, 2021 | 9.17% |
| Jun 30, 2021 | 11.80% |
| Mar 31, 2021 | -150.03% |
| Dec 31, 2020 | 63.20% |
| Sep 30, 2020 | -23.40% |
| Jun 30, 2020 | -23.44% |
| Mar 31, 2018 | -14.76% |
| Dec 31, 2017 | -1,100.90% |
| Sep 30, 2017 | 59.79% |
| Jun 30, 2017 | 77.53% |
| Mar 31, 2017 | -1.28% |
| Dec 31, 2016 | 39.87% |